cDNA microarray-based identification of genes and pathways associated with oxaliplatin resistance Goli SamimiGerald ManorekStephen B. Howell Original Article 16 September 2004 Pages: 1 - 11
Docosahexaenoic acid enhances the susceptibility of human colorectal cancer cells to 5-fluorouracil Gabriella CalvielloFiorella Di NicuoloPaola Palozza Original Article 10 September 2004 Pages: 12 - 20
Pharmacokinetics and pharmacodynamics of 17-demethoxy 17-[[(2-dimethylamino)ethyl]amino]geldanamycin (17DMAG, NSC 707545) in C.B-17 SCID mice bearing MDA-MB-231 human breast cancer xenografts Julie L. EisemanJing LanMerrill J. Egorin Original Article 27 August 2004 Pages: 21 - 32
Phase I study of green tea extract in patients with advanced lung cancer Scott A. LaurieVincent A. MillerKenneth K. Ng Original Article 07 August 2004 Pages: 33 - 38
A dose-finding and pharmacokinetic study of the matrix metalloproteinase inhibitor MMI270 (previously termed CGS27023A) with 5-FU and folinic acid M. EatockJ. CassidyC. Twelves Original Article 10 September 2004 Pages: 39 - 46
Cytotoxic activity of a new paclitaxel formulation, Pacliex, in vitro and in vivo Saadia HassanSumeer DharElin Lindhagen Original Article 20 July 2004 Pages: 47 - 54
Pharmacokinetics of platinum after oral or intravenous cisplatin: a phase 1 study in 32 adult patients Saik UrienEtienne BrainFrançois Lokiec Original Article 28 July 2004 Pages: 55 - 60
Pharmacokinetics and neutrophil toxicity of paclitaxel orally administered in mice with recombinant interleukin-2 Candice JamoisEmmanuelle CometsLaurence Bonhomme-Faivre Original Article 16 September 2004 Pages: 61 - 71
Oral bioavailability of docetaxel in combination with OC144-093 (ONT-093) I. E. L. M. KuppensT. M. BoschJ. H. M. Schellens Original Article 17 August 2004 Pages: 72 - 78
Diosgenin induces cell cycle arrest and apoptosis in human leukemia K562 cells with the disruption of Ca2+ homeostasis Ming-Jie LiuZhao WangQing-Yu Wu Original Article 14 September 2004 Pages: 79 - 90
A phase I and pharmacologic study of the MDR converter GF120918 in combination with doxorubicin in patients with advanced solid tumors A. S. T. PlantingP. SonneveldJ. Verweij Clinical Trial Report 28 July 2004 Pages: 91 - 99